Risk from lithium with acetylcholinesterase inhibitor.
Amante
Alex A
AA
Department of Psychiatry, Southern Illinois University, Springfield, Illinois 62794-9642, USA.
Swartz
Conrad M
CM
D000818:Animals; D018692:Antimanic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006624:Hippocampus / Q000187:drug effects / Q000473:pathology; D006801:Humans; D016651:Lithium Carbonate / Q000008:administration & dosage / Q000009:adverse effects*; D019001:Nitric Oxide Synthase / Q000378:metabolism; D013619:Tacrine / Q000008:administration & dosage / Q000009:adverse effects
D018692:Antimanic Agents; D002800:Cholinesterase Inhibitors; D016651:Lithium Carbonate; D013619:Tacrine; D019001:Nitric Oxide Synthase